Skip to main content
logo
AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
11.64
-0.01 (-0.04%)
Jul 22, 2026, 1:06 PM EDT - Market open

AgomAb Therapeutics NV Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Debt / Equity Ratio
0.010.010.01---
Net Debt / Equity Ratio
-0.88-0.88-0.90---
Net Debt / EBITDA Ratio
1.951.953.56---
Net Debt / FCF Ratio
2.232.233.58---
Quick Ratio
6.276.2718.79---
Current Ratio
6.526.5219.05---
Return on Equity (ROE)
-39.22%-39.22%-49.19%---
Return on Assets (ROA)
-32.92%-32.92%-46.54%---
Return on Invested Capital (ROIC)
-378.95%-350.65%-264.31%---
Return on Capital Employed (ROCE)
-35.67%-35.67%-48.69%---
Buyback Yield / Dilution
-0.00%0.00%-0.00%--
Total Shareholder Return
-0.00%0.00%-0.00%--
SEC Filings: 10-K · 10-Q